Álvaro Avezum

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Salim Yusuf, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet · 2004 · 12K citations · Full text

Medicine, Cardiology, Internal Medicine +15

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Apixaban in Patients with Atrial Fibrillation

Stuart J. Connolly, John W. Eikelboom, Campbell Joyner et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17